IVOB Financials 07/16/2014 07:50:19 INVO BioScien
Post# of 17
Posted On: 07/16/2014 8:50:16 AM
IVOB Financials 07/16/2014 07:50:19
INVO BioScience, Inc.
Period Ending Dec 31, 2010
Total Revenue 68
Cost of Revenue 22
Gross Profit 46
Operating Expenses
Research and Development -
Sales, General and Admin. 1,561
Non-Recurring Items -
Other -
Operating Income (1,515)
Income From Continuing Operations
Add'l Income/Expense Items 1,825
Earnings Before Interest and Tax 310
Interest Expense 463
Earnings Before Tax (153)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (153)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (153)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (153)
INVO BioScience, Inc.
Period Ending Dec 31, 2010
Total Revenue 68
Cost of Revenue 22
Gross Profit 46
Operating Expenses
Research and Development -
Sales, General and Admin. 1,561
Non-Recurring Items -
Other -
Operating Income (1,515)
Income From Continuing Operations
Add'l Income/Expense Items 1,825
Earnings Before Interest and Tax 310
Interest Expense 463
Earnings Before Tax (153)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (153)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (153)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (153)
(0)
(0)INVO BioScience, Inc. (INVO) Stock Research Links
Scroll down for more posts ▼